In parental CRC cells, XRN2 was predominantly localized to the nucleus, whereas in resistant cells, a fraction of XRN2 is colocalized to GDIL-positive loci in cytoplasm (Fig. 7D). This evidence concerns the gene XRN2 and colorectal carcinoma.